Activation of oligodendroglial Stat3 is required for efficient remyelination

Neurobiology of Disease

Volumn 91, Issue , 2016, Pages 336-346

  Steelman, Andrew J ^a,b,d   Zhou, Yun ^a   Koito, Hisami ^a   Kim, SunJa ^a,b   Payne, H Ross ^a   Lu, Q Richard ^c   Li, Jianrong ^a,b  

^a Department of Clinical Sciences   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

CNTF; Myelination; Oligodendrocyte maturation; Remyelination; Stat3 signaling

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; JANUS KINASE 2; LEUKEMIA INHIBITORY FACTOR; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE; STAT3 PROTEIN, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DEMYELINATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE FIBER REGENERATION; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASE; GENETICS; METABOLISM; MULTIPLE SCLEROSIS; MYELIN SHEATH; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASES; MICE; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; RATS, SPRAGUE-DAWLEY; REMYELINATION; STAT3 TRANSCRIPTION FACTOR; STEM CELLS;

EID: 84965070511     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.03.023     Document Type: Article

References (56)

1. Albrecht P.J., Enterline J.C., Cromer J., Levison S.W. CNTF-activated astrocytes release a soluble trophic activity for oligodendrocyte progenitors. Neurochem. Res. 2007, 32(2):263-271.
2. Barres B.A., Schmid R., Sendnter M., Raff M.C. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118(1):283-295.
3. Barres B.A., Burne J.F., Holtmann B., Thoenen H., Sendtner M., Raff M.C. Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol. Cell. Neurosci. 1996, 8(2-3):146-156.
4. Benveniste E.N., Liu Y., McFarland B.C., Qin H. Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis. J. Interf. Cytokine Res. 2014, 34(8):577-588.
5. Blakemore W.F. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J. Neurocytol. 1972, 1(4):413-426.
6. Blakemore W.F. Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone. J. Neurol. Sci. 1973, 20(1):73-83.
7. Bonni A., Sun Y., Nadal-Vicens M., Bhatt A., Frank D.A., Rozovsky I., Stahl N., Yancopoulos G.D., Greenberg M.E. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 1997, 278(5337):477-483.
8. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Stat3 as an oncogene. Cell 1999, 98(3):295-303.
9. Butzkueven H., Zhang J.-G., Soilu-Hanninen M., Hochrein H., Chionh F., Shipham K.A., Emery B., Turnley A.M., Petratos S., Ernst M., et al. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 2002, 8(6):613-619.
10. Chen Y., Balasubramaniyan V., Peng J., Hurlock E.C., Tallquist M., Li J., Lu Q.R. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat. Protoc. 2007, 2(5):1044-1051.
11. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372(9648):1502-1517.
12. Dell'Albani P., Kahn M.A., Cole R., Condorelli D.F., Giuffrida-Stella A.M., de Vellis J. Oligodendroglial survival factors, PDGF-AA and CNTF, activate similar JAK/STAT signaling pathways. J. Neurosci. Res. 1998, 54(2):191-205.
13. Deverman B.E., Patterson P.H. Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination. J. Neurosci. 2012, 32(6):2100-2109.
14. Doerflinger N.H., Macklin W.B., Popko B. Inducible site-specific recombination in myelinating cells. Genesis 2003, 35(1):63-72.
15. Dutta R., McDonough J., Chang A., Swamy L., Siu A., Kidd G.J., Rudick R., Mirnics K., Trapp B.D. Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients. Brain 2007, 130(Pt 10):2566-2576.
16. Dziennis S., Alkayed N.J. Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev. Neurosci. 2008, 19(4-5):341-361.
17. Emery B., Cate H.S., Marriott M., Merson T., Binder M.D., Snell C., Soo P.Y., Murray S., Croker B., Zhang J.G., et al. Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(20):7859-7864.
18. Etxeberria A., Mangin J.-M., Aguirre A., Gallo V. Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum. Nat. Neurosci. 2010, 13(3):287-289.
19. Franklin R.J.M. Why does remyelination fail in multiple sclerosis?. Nat. Rev. Neurosci. 2002, 3(9):705-714.
20. Franklin R.J.M., ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9(11):839-855.
21. Franklin B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, Academic Press, New York, (162 p.).
22. Franklin R.J.M., ffrench-Constant C., Edgar J.M., Smith K.J. Neuroprotection and repair in multiple sclerosis. Nat. Rev. Neurol. 2012, 8(11):624-634.
23. Gao Q., Wolfgang M.J., Neschen S., Morino K., Horvath T.L., Shulman G.I., Fu X.-Y. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(13):4661-4666.
24. He F., Ge W., Martinowich K., Becker-Catania S., Coskun V., Zhu W., Wu H., Castro D., Guillemot F., Fan G., et al. A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat. Neurosci. 2005, 8(5):616-625.
25. Herrmann J.E., Imura T., Song B., Qi J., Ao Y., Nguyen T.K., Korsak R.A., Takeda K., Akira S., Sofroniew M.V. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 2008, 28(28):7231-7243.
26. Huang J.K., Jarjour A.A., Oumesmar B.N., Kerninon C., Williams A., Krezel W., Kagechika H., Bauer J., Zhao C., Baron-Van Evercooren A., et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat. Neurosci. 2011, 14:45-53.
27. Irvine K.A., Blakemore W.F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 2008, 131(6):1464-1477.
28. Ishibashi T., Dakin K.A., Stevens B., Lee P.R., Kozlov S.V., Stewart C.L., Fields R.D. Astrocytes promote myelination in response to electrical impulses. Neuron 2006, 49(6):823-832.
29. Ishibashi T., Lee P.R., Baba H., Fields R.D. Leukemia inhibitory factor regulates the timing of oligodendrocyte development and myelination in the postnatal optic nerve. J. Neurosci. Res. 2009, 87(15):3343-3355.
30. Kerr B.J., Patterson P.H. Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury. Glia 2005, 51(1):73-79.
31. Kim S., Steelman A.J., Koito H., Li J. Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors. J. Neurochem. 2011, 116(1):53-66.
32. Kim S., Steelman A.J., Zhang Y., Kinney H.C., Li J. Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury. Brain Pathol. 2012, 22:41-57.
33. Laterza C., Merlini A., De Feo D., Ruffini F., Menon R., Onorati M., Fredrickx E., Muzio L., Lombardo A., Comi G., et al. iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF. Nat. Commun. 2013, 4:2597.
34. Li J., Ramenaden E.R., Peng J., Koito H., Volpe J.J., Rosenberg P.A. Tumor necrosis factor mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J. Neurosci. 2008, 28(20):5321-5330.
35. Linker R.A., Maurer M., Gaupp S., Martini R., Holtmann B., Giess R., Rieckmann P., Lassmann H., Toyka K.V., Sendtner M., et al. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 2002, 8(6):620-624.
36. Louis J.C., Magal E., Takayama S., Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science (New York, N.Y.) 1993, 259(5095):689-692.
37. Lu Q.R., Sun T., Zhu Z., Ma N., Garcia M., Stiles C.D., Rowitch D.H. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002, 109(1):75-86.
38. Lu Z., Hu X., Zhu C., Wang D., Zheng X., Liu Q. Overexpression of CNTF in mesenchymal stem cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. J. Neuroimmunol. 2009, 206(1-2):58-69.
39. Lu J.Q., Power C., Blevins G., Giuliani F., Yong V.W. The regulation of reactive changes around multiple sclerosis lesions by phosphorylated signal transducer and activator of transcription. J. Neuropathol. Exp. Neurol. 2013, 72(12):1135-1144.
40. Marriott M.P., Emery B., Cate H.S., Binder M.D., Kemper D., Wu Q., Kolbe S., Gordon I.R., Wang H., Egan G., et al. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair. Glia 2008, 56(6):686-698.
41. Modi K.K., Sendtner M., Pahan K. Up-regulation of ciliary neurotrophic factor in astrocytes by aspirin: implications for remyelination in multiple sclerosis. J. Biol. Chem. 2013, 288(25):18533-18545.
42. Monteiro de Castro G., Deja N.A., Ma D., Zhao C., Franklin R.J.M. Astrocyte activation via Stat3 signaling determines the balance of oligodendrocyte versus Schwann cell remyelination. Am. J. Pathol. 2015, 185(9):2431-2440.
43. Nave K.-A. Myelination and support of axonal integrity by glia. Nature 2010, 468(7321):244-252.
44. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 2012, 9(7):671-675.
45. Schweizer U., Gunnersen J., Karch C., Wiese S., Holtmann B., Takeda K., Akira S., Sendtner M. Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult. J. Cell Biol. 2002, 156(2):287-298.
46. Stankoff B., Aigrot M.S., Noel F., Wattilliaux A., Zalc B., Lubetzki C. Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J. Neurosci. 2002, 22(21):9221-9227.
47. Steelman A.J., Thompson J.P., Li J. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication. Neurosci. Res. 2012, 72(1):32-42.
48. Steelman A.J., Smith R., Welsh C.J., Li J. Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis. J. Biol. Chem. 2013, 288(33):23776-23787.
49. Takeda K., Kaisho T., Yoshida N., Takeda J., Kishimoto T., Akira S. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 1998, 161(9):4652-4660.
50. Vernerey J., Macchi M., Magalon K., Cayre M., Durbec P. Ciliary neurotrophic factor controls progenitor migration during remyelination in the adult rodent brain. J. Neurosci. 2013, 33(7):3240-3250.
51. Wegener A., Deboux C., Bachelin C., Frah M., Kerninon C., Seilhean D., Weider M., Wegner M., Nait-Oumesmar B. Gain of Olig2 Function in Oligodendrocyte Progenitors Promotes Remyelination 2015, 120-135.
52. Williams D.A., Tao W., Yang F., Kim C., Gu Y., Mansfield P., Levine J.E., Petryniak B., Derrow C.W., Harris C., et al. Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 2000, 96(5):1646-1654.
53. Xie T.X., Wei D., Liu M., Gao A.C., Ali-Osman F., Sawaya R., Huang S. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004, 23(20):3550-3560.
54. Xin M., Yue T., Ma Z., Wu F.-f., Gow A., Lu Q.R. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J. Neurosci. 2005, 25(6):1354-1365.
55. Zhang Y., Taveggia C., Melendez-Vasquez C., Einheber S., Raine C.S., Salzer J.L., Brosnan C.F., John G.R. Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J. Neurosci. 2006, 26(47):12174-12185.
56. Zhang J., Zhang Y., Dutta D.J., Argaw A.T., Bonnamain V., Seto J., Braun D.A., Zameer A., Hayot F., Lopez C.B., et al. Proapoptotic and antiapoptotic actions of Stat1 versus Stat3 underlie neuroprotective and immunoregulatory functions of IL-11. J. Immunol. 2011, 187(3):1129-1141.